Effect of Iron Chelators on Methemoglobin and Thrombin Preconditioning

Translational Stroke Research

Volumn 3, Issue 4, 2012, Pages 452-459

  Chen Roetling, Jing ^a   Sinanan, Jesse ^a   Regan, Raymond F ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Heme; Intracerebral hemorrhage; Iron; Ischemia; Stroke; Subarachnoid hemorrhage

Indexed keywords

2,2' BIPYRIDINE; DEFEROXAMINE; FERRITIN; HEME OXYGENASE; HEMIN; IRON CHELATING AGENT; METHEMOGLOBIN; THROMBIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL VIABILITY; CHELATION THERAPY; CONTROLLED STUDY; CYTOTOXICITY; GLIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 84869874630     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0195-4     Document Type: Article

References (33)

1. Ardizzone TD, Zhan X, Ander BP, Sharp FR. SRC kinase inhibition improves acute outcomes after experimental intracerebral hemorrhage. Stroke. 2007; 38(5): 1621-5.
2. Park KW, Jin BK. Thrombin-induced oxidative stress contributes to the death of hippocampal neurons: role of neuronal NADPH oxidase. J Neurosci Res. 2008; 86(5): 1053-63. doi: 10. 1002/jnr. 21571.
3. Gong Y, Xi GH, Keep RF, Hoff JT, Hua Y. Complement inhibition attenuates brain edema and neurological deficits induced by thrombin. Acta Neurochir Suppl. 2005; 95: 389-92.
4. Alyash A. Redox and radical reactions of hemoglobin solutions: toxicities and protective strategies. In: Winslow R, editor. Blood Substitutes. London: Academic Press; 2006. p. 197-205.
5. Gu Y, Hua Y, Keep RF, Morgenstern LB, Xi G. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke. 2009; 40(6): 2241-3.
6. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004; 100(4): 672-8.
7. Wu H, Wu T, Li M, Wang J. Efficacy of the lipid-soluble iron chelator 2, 2'-dipyridyl against hemorrhagic brain injury. Neurobiol Dis. 2012; 45(1): 388-94. doi: 10. 1016/j. nbd. 2011. 08. 028.
8. Selim M, Yeatts S, Goldstein JN, Gomes J, Greenberg S, Morgenstern LB, et al. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage. Stroke. 2011; 42(11): 3067-74. doi: 10. 1161/STROKEAHA. 111. 617589.
9. Balla G, Jacob HS, Balla J, Rosenberg M, Nath K, Apple F, et al. Ferritin: a cytoprotective strategem of endothelium. J Biol Chem. 1992; 267(25): 18148-53.
10. Regan RF, Kumar N, Gao F, Guo YP. Ferritin induction protects cortical astrocytes from heme-mediated oxidative injury. Neuroscience. 2002; 113: 985-94.
11. Hua Y, Keep RF, Hoff JT, Xi G. Thrombin preconditioning attenuates brain edema induced by erythrocytes and iron. J Cereb Blood Flow Metab. 2003; 23(12): 1448-54. doi: 10. 1097/01. WCB. 0000090621. 86921. D5.
12. Xi G, Keep RF, Hua Y, Xiang J, Hoff JT. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke. 1999; 30(6): 1247-55.
13. Torti FM, Torti SV. Regulation of ferritin genes and protein. Blood. 2002; 99(10): 3505-16.
14. Chen-Roetling J, Liu W, Regan RF. Iron accumulation and neurotoxicity in cortical cultures treated with holotransferrin. Free Radic Biol Med. 2011; 51(11): 1966-74. doi: 10. 1016/j. freeradbiomed. 2011. 08. 021.
15. Gesuete R, Orsini F, Zanier ER, Albani D, Deli MA, Bazzoni G, et al. Glial cells drive preconditioning-induced blood-brain barrier protection. Stroke. 2011; 42(5): 1445-53. doi: 10. 1161/STROKEAHA. 110. 603266.
16. Li Z, Chen-Roetling J, Regan RF. Increasing expression of H- or L-ferritin protects cortical astrocytes from hemin toxicity. Free Radic Res. 2009; 43(6): 613-21.
17. Jiang Y, Wu J, Hua Y, Keep RF, Xiang J, Hoff JT, et al. Thrombin-receptor activation and thrombin-induced brain tolerance. J Cereb Blood Flow Metab. 2002; 22(4): 404-10. doi: 10. 1097/00004647-200204000-00004.
18. Chen J, Regan RF. Increasing expression of heme oxygenase-1 by proteasome inhibition protects astrocytes from heme-mediated oxidative injury. Curr Neurovasc Res. 2005; 2(3): 189-96.
19. Koh JY, Choi DW. Vulnerability of cultured cortical neurons to damage by excitotoxins: differential susceptibility of neurons containing NADPH-diaphorase. J Neurosci. 1988; 8(6): 2153-63.
20. Chen-Roetling J, Li Z, Chen M, Awe OO, Regan RF. Heme oxygenase activity and hemoglobin neurotoxicity are attenuated by inhibitors of the MEK/ERK pathway. Neuropharmacology. 2009; 56(5): 922-8. doi: 10. 1016/j. neuropharm. 2009. 01. 022.
21. Kakhlon O, Cabantchik ZI. The labile iron pool: characterization, measurement, and participation in cellular processes(1). Free Radic Biol Med. 2002; 33(8): 1037-46.
22. Bradley Jr WG. MR appearance of hemorrhage in the brain. Radiology. 1993; 189(1): 15-26.
23. Kushner JP, Porter JP, Olivieri NF. Secondary iron overload. Hematology. 2001; 2001(1): 47-61.
24. Benvenisti-Zarom L, Regan RF. Astrocyte-specific heme oxygenase-1 hyperexpression attenuates heme-mediated oxidative injury. Neurobiol Dis. 2007; 26(3): 688-95.
25. Warkentin LM, Auriat AM, Wowk S, Colbourne F. Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats. Brain Res. 2010; 1309: 95-103.
26. Whitten CF, Gibson GW, Good MH, Goodwin JF, Brough AJ. Studies in acute iron poisoning. I. Desferrioxamine in the treatment of acute iron poisoning: clinical observations, experimental studies, and theoretical considerations. Pediatrics. 1965; 36(3): 322-35.
27. Chen J, Regan RF. Heme oxygenase-2 gene deletion increases astrocyte vulnerability to hemin. Biochem Biophys Res Commun. 2004; 318: 88-94.
28. Chen-Roetling J, Benvenisti-Zarom L, Regan RF. Cultured astrocytes from heme oxygenase-1 knockout mice are more vulnerable to heme-mediated oxidative injury. J Neurosci Res. 2005; 82(6): 802-10.
29. Cable H, Lloyd JB. Cellular uptake and release of two contrasting iron chelators. J Pharm Pharmacol. 1999; 51(2): 131-4.
30. Nunez MT, Cole ES, Glass J. The reticulocyte plasma membrane pathway of iron uptake as determined by the mechanism of alpha, alpha'-dipyridyl inhibition. J Biol Chem. 1983; 258(2): 1146-51.
31. Martens LK, Kirschner KM, Warnecke C, Scholz H. Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene. J Biol Chem. 2007; 282(19): 14379-88. doi: 10. 1074/jbc. M609857200.
32. Methy D, Bertrand N, Prigent-Tessier A, Mossiat C, Stanimirovic D, Beley A, et al. Beneficial effect of dipyridyl, a liposoluble iron chelator against focal cerebral ischemia: in vivo and in vitro evidence of protection of cerebral endothelial cells. Brain Res. 2008; 1193: 136-42. doi: 10. 1016/j. brainres. 2007. 11. 063.
33. Xi GH, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg. 1998; 89: 991-6.